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ABSTRACT
Articular cartilage injuries are challenging to treat
because of the limited healing potential of articular
cartilage. Various cartilage restoration procedures
have been developed to restore the protective role of
articular cartilage and to delay or prevent additional
damage to the articular surface. ProChondrix® Cartilage
Restoration Matrix is a cryopreserved hyaline cartilage
allograft with viable chondrocytes and growth factors
necessary to promote its incorporation and viability.
We describe a 19-year-old man with a well-contained,
full-thickness cartilage defect on his patella. He
subsequently underwent cartilage restoration with
a ProChondrix® osteochondral allograft. At 1-year
postoperatively, the patient had both clinical and
radiographic evidence of an excellent outcome and had
returned to sport.
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INTRODUCTION
For patients sustaining articular cartilage injuries within
the knee joint, various cartilage repair techniques are
available to prevent or prolong the need for a total
joint replacement. Traditional treatment strategies
include microfracture, osteochondral autograft (OATS),
osteochondral allograft (OCA), and autologous
chondrocyte implantation (ACI).1 Selecting the
appropriate treatment strategy for each patient relies
on the patient’s age, activity level, willingness or
hesitancy to undergo multiple procedures; size and
location of the defect; and whether this is the initial
procedure or a procedure following a failed operation.
Microfracture is considered first-line treatment for
small cartilage lesions less than 2 cm because of its
technical ease, low cost, minimally invasive nature, and

low morbidity.2 However, microfracture biopsies have
shown that the new filling cartilage is predominately
fibrocartilage and only 10.0% hyaline cartilage.3 OATS
type procedures fill cartilage defects with mature,
hyaline articular cartilage immediately. This procedure
is not recommended in defects greater than 4 cm, and
donor site morbidity can be problematic.4 OCA has
emerged as a successful treatment option, with graft
survivorship approaching 80.0% at 10 years.5 OCA
remains limited by cadaver availability, shelf life, and
disease transmission.6 ACI has shown promising results,
with survivorship up to 71.0% at 10 years and 75.0% of
patients showing improvement in function.7 The major
limitations of ACI include the high cost and the need for
a two-stage operation.
Despite the favorable results observed with these
traditional treatment options, cartilage restoration
techniques continue to evolve. One of the recently
developed technologies includes the ProChondrix®
Cartilage Restoration Matrix (AlloSource; Centennial,
CO). This matrix is a cryopreserved hyaline cartilage
allograft prepared on a thin, semi-flexible platform
of bone, with viable chondrocytes and growth
factors necessary to promote its incorporation and
viability. ProChondrix® has been shown to have
87.5% chondrocyte viability at 35 days when utilizing
conventional cryopreservation techniques.8 When
using a proprietary cryopreservation method designed
by AlloSource® (Centennial, CO), ProChondrix® was
found to have a viability of 95.0% at 2 years.9 This
is longer than the current shelf life for conventional
osteochondral allografts, which is 28 days postmortem
when stored at 4˚C.10 To our knowledge, no studies have
been published on the use and outcomes of this implant
in human patients.
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Figure 1. Sagittal A) and axial B) magnetic resonance images of the right knee obtained
after initial injury showing an approximately 1-cm articular defect of the patella and an
articular loose body that can be seen posterior to the posterior cruciate ligament.

CASE REPORT
A 19-year-old man presented after sustaining a
traumatic patella dislocation of his right knee when
playing soccer. He had a history of contralateral patella
dislocation. Findings during patellofemoral examination
showed mild tenderness over the medial patellofemoral
ligament, a medial and lateral patellar glide of 30.0%, 5°
of negative patellar tilt, and a seated Q angle of 25°. He
was very apprehensive during examination maneuvers.
Significant radiographic findings consisted of a small
effusion and an Insall-Salvati ratio of 1.4. Magnetic
resonance imaging (MRI) revealed bone contusions on
the medial patella and lateral femoral condyle, with a
large intra-articular loose body and a significant patellar
defect measuring 1 cm in diameter with adjacent
delamination (Figures 1A and 1B).
At this time, the patient elected to proceed with
arthroscopic debridement of the patellar defect and
loose body removal because of his desire for a short
rehabilitation period and quick return to sport. During
arthroscopy, a well-shouldered, 1-cm diameter, fullthickness cartilage defect was identified on the medial
facet of the patella. The defect was minimally debrided,
and a sizable and delaminated area extending beyond
the injured patellar cartilage surface was recorded.
Over the next year, the patient sustained various
right patellar dislocations with subsequent development
and progression of patellofemoral pain. An MRI and
computed tomography (CT) Fulkerson series were
obtained. Findings showed a large loose body measuring
at least 20 mm in diameter, a large well-circumscribed
patella defect (Figures 2A and 2B), a dysplastic
patellofemoral joint with significant lateral patella
tilt, slight patella subluxation, and the tibia tubercletrochlear groove distance (TTTG) of 25 mm (Figure 3).
At this point, conservative management had
been maximized and was unlikely to prevent further
dislocations. Therefore, 15 months after the initial injury,
the patient underwent operative intervention to address
his multiple patella dislocations, excessive TTTG, lateral
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tilt, lateral subluxation, and large patellar cartilage
defect. The operation included a Fulkerson procedure
with an anteromedial tibia tubercle osteotomy to
address the excessive lateral position of the tibia
tubercle and the patella alta. It also included a lateral
retinaculum release to decrease the negative patellar
tilt and a medial retinacular reefing to decrease the
patella subluxation proximally. To address the cartilage
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Figure 2. Sagittal A) and axial B) magnetic
resonance images showing enlarged
articular defect of the patella 1 year after
initial patellar instability.

modification. An MRI was obtained to investigate
the source of effusion. The Magnetic Resonance
Observation of Cartilage Repair Tissue (MOCART),
MOCART 2, and the Osteochondral Allograft MRI
Scoring System (OCAMRISS) scoring systems were
used to analyze and evaluate the MRI findings (Tables
1 through 3 and Figures 4A and 4B). This patient had a

Figure 3. Computed tomography scan
of the right knee following the Fulkerson
procedure showing a tibial tubercle to
trochlear groove distance of 25 mm.
defect on the patella, which measured approximately
20 mm with a healthy bone base, microfracture was
performed and the defect was repaired using a 20-mm
ProChondrix® graft placed within a fibrin clot to hold
the graft in place.
The postoperative rehab protocol consisted of
bracing with the knee locked in extension for 48 hours.
Once the brace was removed, a continuous passive
motion (CPM) machine was used with a range of
motion of 0° to 90° for 10 hours per day for 4 weeks.11
Immediate weight bearing of 50.0% in full extension
was allowed because of the robust fixation of the tibial
tubercle osteotomy.
At 6 weeks, the patient’s range of motion was 0° to
130°. X-rays confirmed good healing at the osteotomy
site, and he was progressed to full weight bearing and
full range of motion. At 5 months postoperatively, the
patient had returned to running, jogging, and weight
training, including light squats without limits. His range
of motion was full and equal to the uninjured side.
At his 1-year postoperative visit, he had no pain with
activities of daily living, work, or any casual life activity.
The patient was able to walk, jog, and play Frisbee
without any difficulties. After several consecutive days
of skiing, he would get a small effusion that would
go away within 24 hours with ice, rest, and activity
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Figure 4. Sagittal A) and axial B)
magnetic resonance images of the
right knee at 1-year postoperatively
showing filling of the articular defect
with the ProChondrix® allograft and
the incorporation of the graft into the
surrounding native tissue. Filing is at a
similar level compared to the adjacent
articular cartilage.

Table 1. MOCART Scoring
Variable

Score

Degree of defect repair and filling of the defect

Incomplete with greater than 50.0% of the adjacent cartilage

Integration to border zone

Defect visible with less than 50.0% of the length of the repair tissue

Surface of the repair tissue

Surface damaged (fibrillation, fissures, and ulcerations) with less than
50.0% of the repair tissue depth

Structure of the repair

Inhomogenous or cleft formation

Signal intensity of the repair tissue

Moderately hyperintense

Subchondral lamina

Intact

Subchondral bone

Intact

Adhesions

No

Effusion

No

MOCART, Magnetic Resonance Observation of Cartilage Repair Tissue
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Table 2. MOCART 2.0 Scoring
Variable

Score

Volume of cartilage defect filling compared to native cartilage

Underfilling 50.0% to 74.0%

10 points

Integration into adjacent cartilage

Defect greater than 2 mm, but less than 50.0%

5 points

Surface of the repair tissue

Irregularities less than 50%

5 points

Structure of the repair tissue

Inhomogenous

0 points

Signal intensity of the repair tissue

Minor hyperintense

10 points

Bony defect or bony overgrowth

No defect or overgrowth

10 points

Subchondral changes

Edema-like

15 points

MOCART, Magnetic Resonance Observation of Cartilage Repair Tissue

Table 3. OCAMRISS Scoring
Variable

Score

Cartilage signal of graft

Altered intensity (either hypointense or hyperintense, but
not fluid)

1 point

Cartilage “fill” of graft

51.0%-75.0%

1 point

Cartilage edge integration at host-graft junction

Discernable boundary

1 point

Cartilage surface congruity of graft and host-graft junction

Flush

0 points

Calcified cartilage integrity of the graft

Intact, thin, and smooth

0 points

Subchondral bone plate congruity of graft and host-graft junction

Intact and flush

0 points

Subchondral bone marrow signal intensity of graft relative to
epiphyseal bone

Normal

0 points

Osseous integration at host-graft junction

Crossing trabeculae

0 points

Presence of cystic changes of the graft and host-graft junction

Absent

0 points

Opposing cartilage

Abnormal

1 point

OCAMRISS, Osteochondral Allograft MRI Scoring System

MOCART 2.0 score of 50 out of 90 (90 being the best
possible score) and an OCAMRISS score of 4 out of 14
(0 being the best possible score).

DISCUSSION
ProChondrix® is a fresh cartilage matrix with living
chondrocytes designed to maintain the natural signaling
factors vital to the repair and regeneration of hyaline
cartilage. ProChondrix® has been shown to express
bFGF, PRG4, TGF-β, IGF-1, BMP-2, BMP-7, and PDGF.
The growth factors present in ProChondrix® encourage
chondrogenesis and promote bone marrow-derived
cell (BMDC) migration into the surgical site after
being liberated via microfracture. The goal is that the
combination of a live cell-signaling matrix and migration
of BMDCs will lead to the incorporation of the allograft
and form healthy hyaline cartilage.12 ProChondrix®
presents a unique option for contained cartilage defects
as it is readily available, can reconstitute complex
articular surface geometry, restore adequate cartilage
depth, and perform in a single-stage procedure.
ProChondrix® serves as an option for both a primary
repair and as a salvage procedure for chondral defects.
Indications for the use of ProChondrix® include
chondral defects without bone involvement and within
the dimensions of the available implants (11-20 mm).
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Contraindications are chondral injuries with bone
involvement.
To our knowledge, there are no current studies
evaluating outcomes following chondral repair
with ProChondrix® allograft in humans. At 1-year
postoperatively, the patient displayed excellent clinical
results. He had returned to running and skiing and had
no pain with activities of daily living, work, or causal
life. An MRI was obtained due to intermittent joint
effusions. It showed the graft had become incorporated
with the surrounding native tissue, and there was
filling of the defect to a similar level compared to the
adjacent cartilage. However, given this patient had
multiple, simultaneous operations with his chondral
repair using ProChondrix®, it is impossible to quantify
how much of his outcome is attributable to the
chondral repair alone.
We used the MOCART,13 MOCART 2.0,14 and
OCAMRISS15 grading systems to analyze the MRI
and grade graft incorporation. Previous studies have
compared MRI findings of the individual components of
both the MOCART to clinical outcomes6 and OCAMRISS
to histologic findings8 to validate these scoring
systems. There is currently a lack of strong evidence
to suggest MRI scoring systems reliably correlate with
clinical outcomes.16 Therefore, we felt it was pertinent

to explore this correlation in the case reported here.
This patient had a MOCART 2.0 score of 50 out of 90
(90 being the best possible score) and an OCAMRISS
score of 4 out of 14 (0 being the best possible score)
in the setting of an excellent clinical outcome. Again,
we cannot attribute this outcome entirely to the
ProChondrix® chondral repair because of the other
operations performed.
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